Human Chimeric PL-7 IgG antibody

<strong>Human Chimeric PL-7 IgG antibody </strong>_x000D_ <strong>Catalog number:</strong> B2013619_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 0.1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> PL-7 humAb IgG_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review Autoimmun Rev. 2014 Apr-May;13(4-5):367-71._x000D_ 2: Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China BMC Pulm Med. 2021 Feb 12;21(1):57._x000D_ 3: Damoiseaux J, Vulsteke JB, Tseng CW, Platteel ACM, Piette Y, Shovman O, Bonroy C, Hamann D, De Langhe E, Musset L, Chen YH, Shoenfeld Y, Allenbach Y, Bossuyt X. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays Autoimmun Rev. 2019 Mar;18(3):293-305._x000D_ 4: Blake T, Noureldin B. Anti-PL-7 antisynthetase syndrome presenting as COVID-19 Rheumatology (Oxford). 2021 Jul 1;60(7):e252-e254._x000D_ 5: Preage C, Paesler B, Nelke C, Cengiz D, Müntefering T, Roos A, Amelin D, Allenbach Y, Uruha A, Dittmayer C, Hentschel A, Pawlitzki M, Hoffmann S, Timm S, Louis SL, Dengler NF, Wiendl H, Lünemann JD, Sickmann A, Hervier B, Meuth SG, Schneider U, Schanze A, Krause S, Tomaras S, Feist E, Hasseli R, Goebel HH, Gallay L, Streichenberger N, Benveniste O, Stenzel W, Ruck T. Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis Acta Neuropathol. 2022 Aug;144(2):353-372._x000D_ 6: Labirua-Iturburu A, Selva-O'Callaghan A, Vincze M, Dankó K, Vencovsky J, Fisher B, Charles P, Dastmalchi M, Lundberg IE. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature Medicine (Baltimore). 2012 Jul;91(4):206-211._x000D_ 7: Fujimoto M. [Myositis-specific autoantibodies] Brain Nerve. 2013 Apr;65(4):449-60._x000D_ 8: Saito G, Kono M, Tsutsumi A, Koyanagi Y, Miyashita K, Kobayashi T, Hozumi H, Miki Y, Arai Y, Otsuki Y, Hashimoto D, Fujisawa T, Nakamura T, Suda T, Nakamura H. Anti-PL-7 Antisynthetase Syndrome with Eosinophilic Pleural Effusion Intern Med. 2018 Aug 1;57(15):2227-2232._x000D_ 9: Souza FH, Cruellas MG, Levy-Neto M, Shinjo SK. [Anti-synthetase syndrome: anti-PL-7, anti-PL-12 and anti-EJ] Rev Bras Reumatol. 2013 Aug;53(4):352-7._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/25394672">10: Tomonaga M, Sakamoto N, Ishimatsu Y, Kakugawa T, Harada T, Nakashima S, Hara A, Hara S, Horai Y, Kawakami A, Mukae H, Kohno S. Comparison of pulmonary involvement between patients expressing anti-PL-7 and anti-Jo-1 antibodies Lung. 2015 Feb;193(1):79-83. </a>_x000D_ _x000D_ <strong>Products Related to Human Chimeric PL-7 IgG antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>